Asamli, Kaiser U.
HRN: 21-47-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/25/2022
07/31/2022
IV
4.5g
Q6h
Pleural Abscess, Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes